Indofarma Corruption Case Rp371 Billion, Former President Director Allegedly Buys Fictitious Medical Devices

One of the suspects in the alleged corruption case in the financial management of PT Indofarma which was detained by the Jakarta High Prosecutor's Office (Kejati), Thursday, September 19, 2024. (Rizky AP/VOI)

JAKARTA - The Jakarta High Prosecutor's Office (Kejati) has named three suspects in the alleged corruption case of PT Indofarma's financial management. One of them is the former President Director of Indofarma Arief Pramuhanto (AP) who is suspected of manipulating financial reports by buying fictitious medical devices (alkes).

Assistant for Special Crimes (Aspidsus) of the Jakarta High Prosecutor's Office, Syarief Sulaeman Nahdi, said that apart from AP, his party also ensnared two other perpetrators, namely GSR as Director of PT Indofarma Global Medika and CSY as Head of Finance of PT IGM in 2019-2021.

In this case, Arief Pramhhanto played a role in manipulating PT Indofarma's finances. This was done to buy fictitious medical equipment products, as if the company's targets were met.

Meanwhile, GSR colludes with CSY to make fictitious discount claims from several vendors to fulfill PT Indofarma's operations.

"The suspects have harmed the state in the amount of Rp 371 billion," Syarief said in his statement, Friday, September 20.

For their actions, the three suspects were charged with Article 2 paragraph (1), Article 3 in conjunction with Article 18 paragraph (1) of Law (UU) Number 31 of 1999 as amended by Law (UU) Number 20 of 2001 concerning Amendments to Law Number 31 of 1999 concerning Eradication of Criminal Acts of Corruption in conjunction with Article 55 paragraph (1) 1st of the Criminal Code in conjunction with Article 64 paragraph (1) of the Criminal Code.

"For investigation purposes, AP is being held at the Central Jakarta Class 1 state detention center, GSR at the Salemba Rutan, the Attorney General's Branch and the CSY suspect at the Salemba Rutan, South Jakarta District Attorney's Branch for the next 20 days," said Syarief.